中药联合必可酮雾化吸入治疗小儿咳嗽变异性哮喘30例临床观察

Clinical Observation on Treatment for 30 Cases of Infantile Cough Variant Asthma with Herbs and Atomized Becotide Spray for Inhalation

目的:中药联合必可酮雾化吸入治疗咳嗽变异性哮喘的临床疗效。方法:将符合病例入选标准的60例患儿随机分为观察组、对照组各30例。2组患儿均给予必可酮喷雾剂,100μg/次,雾化吸入,2次/d。观察组同时给予中药雾化吸入,20 mi n/次,2次/d。2组均以治疗7天为1个疗程。结果:临床控制率观察组为63.33%,对照组为46.67%,2组相比差异有统计学意义(P<0.05)。总有效率观察组为96.67%,对照组为83.33%,2组相比差异有统计学意义(P<0.05)。日间症状评分、夜间症状评分2组治疗后均明显改善(P<0.05),且观察组优于对照组(P<0.05)。结论:中药联合必可酮雾化吸入治疗咳嗽变异性哮喘临床疗效显著。

Objective： To study clinical effects of herbs and atomized becotide spray in treating cough variant asthma. Method： Sixty cases were randomized into the observation group and the control group. Both groups received becotide spray, 100 μg/time, atomized for inhalation, twice each day. The observation group received atomized herb for inhalation, 20 minutes each time, twice each day. One course of treatment was seven days. Result： Control rate of the observation group was 63.33%, higher than 46.67% of the control group with statistical meaning （P〈0.05）. Total effective rate of the observation group was 96.67%, superior to 83.33% of the control group with statistical meaning （P 〈0.05）. Symptom scales in the daytime and the night of both groups were improved significantly（P〈0.05）, and the observation group was superior to the control group（P〈0.05）. Conclusion： Atomized herb and becotide spray for inhalation could obtain clinical effects in treating cough variant asthma.